India hospital covid-19 testing patient India

Gilead to test inhaled version of remdesivir on COVID-19 patients next month

Reading now: 671
www.livemint.com

BENGALURU : Gilead Sciences Inc said on Monday that it plans to begin clinical trials of an inhaled version of its antiviral treatment remdesivir for COVID-19 patients in August.The drug is currently used intravenously and an inhaled formulation would be given through a nebulizer, which could potentially allow for easier administration outside hospitals, the company said in a statement.Click here to read the Mint ePaperLivemint.com is now on Telegram.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA